TKI- 注文

  • 商品説明・詳細

  • 送料・お届け

商品情報

未使用


着払いで発送します

TKI | Thomas-Kilmann Conflict Mode Instrument
TKI | Thomas-Kilmann Conflict Mode Instrument

Schematic representation of mechanism of action of tyrosine kinase... |  Download Scientific Diagram
Schematic representation of mechanism of action of tyrosine kinase... | Download Scientific Diagram

Applying the Thomas-Kilmann Conflict Model: A Guide to TKI Assessment |  Hone Consulting
Applying the Thomas-Kilmann Conflict Model: A Guide to TKI Assessment | Hone Consulting

Thomas-Kilmann Conflict Mode Instrument (TKI®) | The Myers-Briggs Company
Thomas-Kilmann Conflict Mode Instrument (TKI®) | The Myers-Briggs Company

Complete Remission With Tyrosine Kinase Inhibitors in Renal Cell Carcinoma  | Journal of Clinical Oncology
Complete Remission With Tyrosine Kinase Inhibitors in Renal Cell Carcinoma | Journal of Clinical Oncology

Team Discovers how TKI Cancer Drugs Cause Inflammatory Side Effects | Asia  Research News
Team Discovers how TKI Cancer Drugs Cause Inflammatory Side Effects | Asia Research News


Frontiers | Development of EGFR TKIs and Options to Manage Resistance of  Third-Generation EGFR TKI Osimertinib: Conventional Ways and Immune  Checkpoint Inhibitors
Frontiers | Development of EGFR TKIs and Options to Manage Resistance of Third-Generation EGFR TKI Osimertinib: Conventional Ways and Immune Checkpoint Inhibitors

Molecular and Clinical Features of EGFR-TKI-Associated Lung Injury
Molecular and Clinical Features of EGFR-TKI-Associated Lung Injury

TKI Group
TKI Group

Tyrosine Kinase-Inhibitor (TKI)-sensitive and-resistant Tumors and the... |  Download Scientific Diagram
Tyrosine Kinase-Inhibitor (TKI)-sensitive and-resistant Tumors and the... | Download Scientific Diagram

Mechanisms and management of 3rd‑generation EGFR‑TKI resistance in advanced  non‑small cell lung cancer (Review)
Mechanisms and management of 3rd‑generation EGFR‑TKI resistance in advanced non‑small cell lung cancer (Review)

Home - TKI Construction
Home - TKI Construction

Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular  mechanisms and future perspective | Signal Transduction and Targeted Therapy
Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective | Signal Transduction and Targeted Therapy

An Overview of the TKI Assessment Tool - Kilmann Diagnostics
An Overview of the TKI Assessment Tool - Kilmann Diagnostics

残り 4 59,800円

(995 ポイント還元!)

翌日お届け可(営業日のみ) ※一部地域を除く

お届け日: 02月06日〜指定可 (明日13:00のご注文まで)

  • ラッピング
    ラッピング
希望しない
希望する ( +600円 )
希望しない
数量
同時に5点までのご購入が可能です。
お気に入りに保存

対応決済方法

クレジットカード
クレジットカード決済
コンビニ前払い決済
コンビニ決済
代金引換
商品到着と引き換えにお支払いいただけます。 (送料を含む合計金額が¥284,562 まで対応可能)
ペイジー前払い決済(ATM/ネットバンキング)
以下の金融機関のATM/ネットバンクからお支払い頂けます
みずほ銀行 、 三菱UFJ銀行 、 三井住友銀行
りそな銀行 、ゆうちょ銀行、各地方銀行
Amazon Pay(Amazonアカウントでお支払い)

大量注文に関して

30個以上かつ10万円以上のご購入はこちらからお問い合わせください

お問い合わせはこちらから